Relationship between antibiotic use and incidence of mexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 3, 2008, Pages 1173-1175

  Hocquet, Didier ^a,d   Muller, Arno ^b   Blanc, Karine ^a   Plésiat, Patrick ^a   Talon, Daniel ^c   Monnet, Dominique Louis ^b   Bertrand, Xavier ^c  

^a National Reference Centre for Antibiotic Resistance P Aeruginosa   (France)

^b National Center for Antimicrobials and Infection Control   (Denmark)

^c UNIVERSITY HOSPITAL OF BESANÇON   (France)

^d UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN; AZITHROMYCIN; AZTREONAM; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLAVULANIC ACID; CLOXACILLIN; COLISTIN; ERTAPENEM; ERYTHROMYCIN; FOSFOMYCIN; GENTAMICIN; IMIPENEM; LINEZOLID; MEROPENEM; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; INCIDENCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TIME SERIES ANALYSIS;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CEPHALOSPORINS; CULTURE MEDIA; DRUG RESISTANCE, MULTIPLE; FLUOROQUINOLONES; FRANCE; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 40549118163     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01212-07     Document Type: Article

References (12)

1. Aires, J. R., T. Köhler, H. Nikaido, and P. Plésiat. 1999. Involvement of an efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 43:2624-2628.
2. Dumas, J.-L., C. Delden, K. Perron, and T. Köhler. 2006. Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR. FEMS Microbiol. Lett. 254:217-225.
3. Dupont, P., D. Hocquet, K. Jeannot, P. Chavanet, and P. Plesiat. 2005. Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa. J. Antimicrob. Chemother. 55:518-522.
4. Hocquet, D., P. Berthelot, M. Roussel-Delvallez, R. Favre, K. Jeannot, O. Bajolet, N. Marty, F. Grattard, P. Mariani-Kurkdjian, E. Bingen, M. O. Husson, G. Couetdic, and P. Plésiat. 2007. Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections. Antimicrob. Agents Chemother. 51:3531-3536.
5. Hocquet, D., A. Muller, K. Blanc, P. Plésiat, D. Talon, D. L. Monnet, and X. Bertrand. 2007. Abstr. 17th Eur. Congr. Clin. Microbiol. Infect. Dis., abstr. 0257.
6. Hocquet, D., P. Nordmann, F. El Garch, L. Cabanne, and P. Plésiat. 2006. Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 50:1347-1351.
7. Hocquet, D., M. Roussel-Delvallez, J. D. Cavallo, and P. Plésiat. 2007. MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin. Antimicrob. Agents Chemother. 51:1582-1583.
8. Lianes, C., D. Hocquet, C. Vogne, D. Bénali-Baitich, C. Neuwirth, and P. Plésiat. 2004. Clinical strains of Pseudomonas aeruginosa overproducing simultaneously MexAB-OprM and MexXY efflux pumps. Antimicrob. Agents Chemother. 48:1797-1802.
9. Lomovskaya, O., A. Lee, K. Hoshino, H. Ishida, A. Mistry, M. S. Warren, E. Boyer, S. Chamberland, and V. J. Lee. 1999. Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43:1340-1346.
10. Muller, A., J. M. Lopez-Lozano, X. Bertrand, and D. Talon. 2004. Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae. J. Antimicrob. Chemother. 54:173-177.
11. Pankratz, A. 1991. Forecasting with dynamic regression models. Wiley, New York, NY.
12. Zelenitsky, S. A., G. K. Harding, S. Sun, K. Ubhi, and R. E. Ariane. 2003. Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis. J. Antimicrob. Chemother. 52:668-674.